Search

Author/Creator Valk, Peter J. M.

1. A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia. (24th November 2015)

Authors:
Niavarani, Ahmadreza; Herold, Tobias; Reyal, Yasmin; Sauerland, Maria C.; Buchner, Thomas; Hiddemann, Wolfgang; Bohlander, Stefan K.; Valk, Peter J. M.; Bonnet, Dominique
Journal:
British journal of haematology
Issue:
Volume 172:Number 3(2016)
Page Start:
401
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony‐stimulating factor. Issue 4 (31st October 2022)

Authors:
Feyen, Jacqueline; Ernst, Martijn P. T.; van der Velden, Vincent H. J.; Valk, Peter J. M.; Broeders, Lianne; Touw, Ivo P.; Raaijmakers, Marc H. G. P.
Journal:
Pediatric blood & cancer
Issue:
Volume 70:Issue 4(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation. Issue 9 (2nd May 2021)

Authors:
Engen, Caroline; Hellesøy, Monica; Grob, Tim; Al Hinai, Adil; Brendehaug, Atle; Wergeland, Line; Bedringaas, Siv Lise; Hovland, Randi; Valk, Peter J. M.; Gjertsen, Bjørn T.
Journal:
Molecular oncology
Issue:
Volume 15:Issue 9(2021)
Page Start:
2300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. MiR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2. Issue 1 (3rd December 2020)

Authors:
Vandewalle, Virginie; Essaghir, Ahmed; Bollaert, Emeline; Lenglez, Sandrine; Graux, Carlos; Schoemans, Hélène; Saussoy, Pascale; Michaux, Lucienne; Valk, Peter J. M.; Demoulin, Jean‐Baptiste; Havelange, Violaine
Journal:
Journal of cellular and molecular medicine
Issue:
Volume 25:Issue 1(2021)
Page Start:
575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Recurrently affected genes in juvenile myelomonocytic leukaemia. (9th May 2017)

Authors:
Obenauer, Julia C.; Kavelaars, François G.; Sanders, Mathijs A.; de Vries, Andrica C. H.; de Haas, Valerie; Beverloo, H. Berna; De Moerloose, Barbara; Lammens, Tim; Dworzak, Michael; Hoogenboezem, Remco M.; Valk, Peter J. M.; Touw, Ivo P.; van den Heuvel‐Eibrink, Marry M.
Journal:
British journal of haematology
Issue:
Volume 182:Number 1(2018)
Page Start:
135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The actin‐binding protein CORO1A is a novel PU.1 (SPI1)‐ and CEBPA‐regulated gene with significantly lower expression in APL and CEBPA‐mutated AML patients. (17th December 2012)

Authors:
Federzoni, Elena A.; Humbert, Magali; Valk, Peter J. M.; Behre, Gerhard; Leibundgut, Elisabeth O.; Torbett, Bruce E.; Fey, Martin F.; Tschan, Mario P.
Journal:
British journal of haematology
Issue:
Volume 160:Number 6(2013:Mar.)
Page Start:
855
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed. (24th December 2021)

Authors:
Bakunina, Katerina; Putter, Hein; Versluis, Jurjen; Koster, Eva A. S.; van der Holt, Bronno; Manz, Markus G.; Breems, Dimitri A.; Gjertsen, Bjorn T.; Cloos, Jacqueline; Valk, Peter J. M.; Passweg, Jakob; Pabst, Thomas; Ossenkoppele, Gert J.; Löwenberg, Bob; Cornelissen, Jan J.; de Wreede, Liesbet...
Journal:
Cancer medicine
Issue:
Volume 11:Number 3(2022)
Page Start:
630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗